Navigating Rising Health Care Costs: The Role of Reference Pricing in Insurance

Health care expenditure constitutes about 18% of the U.S. economy and represents a significant portion of federal spending. A major driver behind escalating health care costs, particularly in commercial insurance, is the surge in medical care prices, which have increased by 130% since 2000, outpacing overall inflation at 93%. This rise affects commercial insurance markets, including large organizations, Affordable Care Act (ACA) marketplaces, and public employers, imposing financial strain on employees, businesses, and the federal government.

Cost Mitigation Strategies

To manage these increasing costs, many employers collaborate with payers to negotiate with healthcare providers, but often lack the leverage to secure favorable terms. Public employers are turning to reference pricing to manage expenses in state employee health plans. This involves setting a cap on the amount paid for specific medical services, which has led to reduced state budget expenditures and lower employee healthcare costs in states adopting this strategy.

Potential of Reference Pricing

Policymakers could consider applying reference pricing to federally subsidized insurance plans for broader cost reductions. The Federal Employees Health Benefits (FEHB) program, a significant employer-sponsored insurance plan, could be a pilot, with potential for substantial savings. Implementing reference pricing using Medicare reimbursement rates, set at 200% of these rates, could yield considerable savings over a decade.

Case Studies and Implications

States like California, Montana, and Oregon have adopted reference pricing with varied success. California saw cost savings and directed enrollees to cost-effective providers, while Montana used Medicare rates for in-network services, achieving significant budget cuts. Oregon’s model reduced both hospital payments and out-of-pocket costs without compromising hospital operations or care quality.

Considerations for Implementation

The FEHB program could enhance affordability by emulating state models of reference pricing, which offer insights into effective practices. Challenges include maintaining provider network participation and ensuring proper enrollee education and incentive structures. Balancing efficiency with provider sustainability and considering local market conditions and Medicare’s pricing methodology are crucial for setting appropriate reference prices.

As health expenditures continue to grow, reference pricing in programs like the FEHB offers a significant opportunity for cost control, potential savings, and a model for federally subsidized insurance schemes. Thorough analysis and strategic implementation can address programmatic considerations, optimizing benefits for both beneficiaries and the government.